<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30241184</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">2378-9506</ISSN>                <JournalIssue CitedMedium="Internet">                    <Issue>4</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                    </PubDate>                </JournalIssue>                <Title>Journal of global oncology</Title>                <ISOAbbreviation>J Glob Oncol</ISOAbbreviation>            </Journal>            <ArticleTitle>Comparison of Receptor-Defined Breast Cancer Subtypes Between German and Sudanese Women: A Facility-Based Cohort Study.</ArticleTitle>            <Pagination>                <MedlinePgn>1-12</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1200/JGO.2017.010082</ELocationID>            <Abstract>                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The objective of this study was to compare tumor characteristics, biomarkers, and surrogate subtypes of breast cancer between Sudanese and German women.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">Tumor characteristics and immunohistochemistry markers (estrogen receptor [ER], progesterone receptor [PR], and human epidermal growth factor receptor 2 [HER2]) were collected from the routine assessment of consecutive patients with invasive breast cancer diagnosed from 2010 to 2015 (Gezira University Pathology Laboratory, Gezira, Sudan) and from 1999 to 2013 (Breast Centre, Martin-Luther-University, Halle, Germany).</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 2,492 patients (German [n = 1,932] and Sudanese [n = 560]) were included. Age at diagnosis ranged from 20 to 94 years. Sudanese women were, on average, 10 years younger than German women, with a mean (Â± standard deviation) age of 48.8 (13.5) and 58.6 (12.4) years, respectively. The Sudanese women had a higher grade, larger tumor, and more lymph node positivity compared with German women. ER-, PR-, and HER2-negative proportions were 55%, 61.8%, and 71.3%, respectively, for Sudanese women versus 22.7%, 32.3%, and 82.5%, respectively, for German women. The triple-negative subtype was more prevalent in Sudanese women (34.5%) than in German women (14.2%). The strongest factor associated with ER-negative disease was grade III (odds ratio, 19.6; 95% CI 11.6 to 33.4; P &lt; .001). Sudanese patients were at higher risk for ER-negative breast cancer, with an odds ratio of 2.01 ( P = .001; adjusted for age, size, nodal status, histologic type, and grade). Stratified by grade, the influence of origin was observed in grade I and grade II tumors, but not in grade III tumors.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Sudanese women had more aggressive tumor characteristics and unfavorable prognostic biomarkers. After adjustment, Sudanese origin was still associated with hormone receptor-negative disease, especially in grade I and II tumors. These findings suggest differences in tumor biology among these ethnic groups.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Sengal</LastName>                    <ForeName>Asmerom Tesfamariam</ForeName>                    <Initials>AT</Initials>                    <AffiliationInfo>                        <Affiliation>Asmerom Tesfamariam Sengal, Nada Suliman Haj Mukhtar, Ahmed Mohammed Elhaj, and Ahmed Abdalla Mohamedani, University of Gezira, Gezira, Sudan; Asmerom Tesfamariam Sengal, Orotta School of Medicine and Dentistry, Asmara, Eritrea; Martina Vetter, Christoph Thomssen, Claudia Wickenhauser, and Eva Johanna Kantelhardt, Martin-Luther-University Halle-Wittenberg, Halle, Germany; Shahinaz Bedri, Weill Cornell Medicine-Qatar, Doha, Qatar; and Steffen Hauptmann, Maastricht University Medical Centre, Maastricht, the Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Haj Mukhtar</LastName>                    <ForeName>Nada Suliman</ForeName>                    <Initials>NS</Initials>                    <AffiliationInfo>                        <Affiliation>Asmerom Tesfamariam Sengal, Nada Suliman Haj Mukhtar, Ahmed Mohammed Elhaj, and Ahmed Abdalla Mohamedani, University of Gezira, Gezira, Sudan; Asmerom Tesfamariam Sengal, Orotta School of Medicine and Dentistry, Asmara, Eritrea; Martina Vetter, Christoph Thomssen, Claudia Wickenhauser, and Eva Johanna Kantelhardt, Martin-Luther-University Halle-Wittenberg, Halle, Germany; Shahinaz Bedri, Weill Cornell Medicine-Qatar, Doha, Qatar; and Steffen Hauptmann, Maastricht University Medical Centre, Maastricht, the Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Vetter</LastName>                    <ForeName>Martina</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Asmerom Tesfamariam Sengal, Nada Suliman Haj Mukhtar, Ahmed Mohammed Elhaj, and Ahmed Abdalla Mohamedani, University of Gezira, Gezira, Sudan; Asmerom Tesfamariam Sengal, Orotta School of Medicine and Dentistry, Asmara, Eritrea; Martina Vetter, Christoph Thomssen, Claudia Wickenhauser, and Eva Johanna Kantelhardt, Martin-Luther-University Halle-Wittenberg, Halle, Germany; Shahinaz Bedri, Weill Cornell Medicine-Qatar, Doha, Qatar; and Steffen Hauptmann, Maastricht University Medical Centre, Maastricht, the Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Elhaj</LastName>                    <ForeName>Ahmed Mohammed</ForeName>                    <Initials>AM</Initials>                    <AffiliationInfo>                        <Affiliation>Asmerom Tesfamariam Sengal, Nada Suliman Haj Mukhtar, Ahmed Mohammed Elhaj, and Ahmed Abdalla Mohamedani, University of Gezira, Gezira, Sudan; Asmerom Tesfamariam Sengal, Orotta School of Medicine and Dentistry, Asmara, Eritrea; Martina Vetter, Christoph Thomssen, Claudia Wickenhauser, and Eva Johanna Kantelhardt, Martin-Luther-University Halle-Wittenberg, Halle, Germany; Shahinaz Bedri, Weill Cornell Medicine-Qatar, Doha, Qatar; and Steffen Hauptmann, Maastricht University Medical Centre, Maastricht, the Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bedri</LastName>                    <ForeName>Shahinaz</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Asmerom Tesfamariam Sengal, Nada Suliman Haj Mukhtar, Ahmed Mohammed Elhaj, and Ahmed Abdalla Mohamedani, University of Gezira, Gezira, Sudan; Asmerom Tesfamariam Sengal, Orotta School of Medicine and Dentistry, Asmara, Eritrea; Martina Vetter, Christoph Thomssen, Claudia Wickenhauser, and Eva Johanna Kantelhardt, Martin-Luther-University Halle-Wittenberg, Halle, Germany; Shahinaz Bedri, Weill Cornell Medicine-Qatar, Doha, Qatar; and Steffen Hauptmann, Maastricht University Medical Centre, Maastricht, the Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hauptmann</LastName>                    <ForeName>Steffen</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Asmerom Tesfamariam Sengal, Nada Suliman Haj Mukhtar, Ahmed Mohammed Elhaj, and Ahmed Abdalla Mohamedani, University of Gezira, Gezira, Sudan; Asmerom Tesfamariam Sengal, Orotta School of Medicine and Dentistry, Asmara, Eritrea; Martina Vetter, Christoph Thomssen, Claudia Wickenhauser, and Eva Johanna Kantelhardt, Martin-Luther-University Halle-Wittenberg, Halle, Germany; Shahinaz Bedri, Weill Cornell Medicine-Qatar, Doha, Qatar; and Steffen Hauptmann, Maastricht University Medical Centre, Maastricht, the Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Thomssen</LastName>                    <ForeName>Christoph</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Asmerom Tesfamariam Sengal, Nada Suliman Haj Mukhtar, Ahmed Mohammed Elhaj, and Ahmed Abdalla Mohamedani, University of Gezira, Gezira, Sudan; Asmerom Tesfamariam Sengal, Orotta School of Medicine and Dentistry, Asmara, Eritrea; Martina Vetter, Christoph Thomssen, Claudia Wickenhauser, and Eva Johanna Kantelhardt, Martin-Luther-University Halle-Wittenberg, Halle, Germany; Shahinaz Bedri, Weill Cornell Medicine-Qatar, Doha, Qatar; and Steffen Hauptmann, Maastricht University Medical Centre, Maastricht, the Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mohamedani</LastName>                    <ForeName>Ahmed Abdalla</ForeName>                    <Initials>AA</Initials>                    <AffiliationInfo>                        <Affiliation>Asmerom Tesfamariam Sengal, Nada Suliman Haj Mukhtar, Ahmed Mohammed Elhaj, and Ahmed Abdalla Mohamedani, University of Gezira, Gezira, Sudan; Asmerom Tesfamariam Sengal, Orotta School of Medicine and Dentistry, Asmara, Eritrea; Martina Vetter, Christoph Thomssen, Claudia Wickenhauser, and Eva Johanna Kantelhardt, Martin-Luther-University Halle-Wittenberg, Halle, Germany; Shahinaz Bedri, Weill Cornell Medicine-Qatar, Doha, Qatar; and Steffen Hauptmann, Maastricht University Medical Centre, Maastricht, the Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wickenhauser</LastName>                    <ForeName>Claudia</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Asmerom Tesfamariam Sengal, Nada Suliman Haj Mukhtar, Ahmed Mohammed Elhaj, and Ahmed Abdalla Mohamedani, University of Gezira, Gezira, Sudan; Asmerom Tesfamariam Sengal, Orotta School of Medicine and Dentistry, Asmara, Eritrea; Martina Vetter, Christoph Thomssen, Claudia Wickenhauser, and Eva Johanna Kantelhardt, Martin-Luther-University Halle-Wittenberg, Halle, Germany; Shahinaz Bedri, Weill Cornell Medicine-Qatar, Doha, Qatar; and Steffen Hauptmann, Maastricht University Medical Centre, Maastricht, the Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kantelhardt</LastName>                    <ForeName>Eva Johanna</ForeName>                    <Initials>EJ</Initials>                    <AffiliationInfo>                        <Affiliation>Asmerom Tesfamariam Sengal, Nada Suliman Haj Mukhtar, Ahmed Mohammed Elhaj, and Ahmed Abdalla Mohamedani, University of Gezira, Gezira, Sudan; Asmerom Tesfamariam Sengal, Orotta School of Medicine and Dentistry, Asmara, Eritrea; Martina Vetter, Christoph Thomssen, Claudia Wickenhauser, and Eva Johanna Kantelhardt, Martin-Luther-University Halle-Wittenberg, Halle, Germany; Shahinaz Bedri, Weill Cornell Medicine-Qatar, Doha, Qatar; and Steffen Hauptmann, Maastricht University Medical Centre, Maastricht, the Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2017</Year>                <Month>08</Month>                <Day>04</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>J Glob Oncol</MedlineTA>            <NlmUniqueID>101674751</NlmUniqueID>            <ISSNLinking>2378-9506</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2015 Mar 14;385(9972):977-1010</RefSource>                <PMID Version="1">25467588</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2002 Jun;74(3):199-211</RefSource>                <PMID Version="1">12206512</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Pathol. 2002 Jan;196(1):32-6</RefSource>                <PMID Version="1">11748639</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2008 Jul;15(7):1983-8</RefSource>                <PMID Version="1">18408976</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2009 Sep 20;27(27):4515-21</RefSource>                <PMID Version="1">19704069</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ghana Med J. 2012 Mar;46(1):8-13</RefSource>                <PMID Version="1">22605883</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast J. 2014 May-Jun;20(3):308-11</RefSource>                <PMID Version="1">24708149</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pan Afr Med J. 2014 Apr 05;17:249</RefSource>                <PMID Version="1">25309649</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2000 Aug 17;406(6797):747-52</RefSource>                <PMID Version="1">10963602</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2007 Apr;102(2):189-99</RefSource>                <PMID Version="1">17333343</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Diagn Pathol. 2014 Feb;18(1):21-6</RefSource>                <PMID Version="1">24321463</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS Med. 2014 Sep 09;11(9):e1001720</RefSource>                <PMID Version="1">25202974</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol. 2009;8(7):62</RefSource>                <PMID Version="1">19664200</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2008 Jan 29;98(2):277-81</RefSource>                <PMID Version="1">18182985</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2011 Aug;22(8):1736-47</RefSource>                <PMID Version="1">21709140</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2008 Jul;110(1):183-8</RefSource>                <PMID Version="1">17674190</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Histopathology. 1991 Nov;19(5):403-10</RefSource>                <PMID Version="1">1757079</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>APMIS. 2007 Dec;115(12):1391-9</RefSource>                <PMID Version="1">18184410</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2010 Dec 15;16(24):6100-10</RefSource>                <PMID Version="1">21169259</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Rev Environ Health. 2010 Jul-Sep;25(3):221-42</RefSource>                <PMID Version="1">21038757</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS Pathog. 2016 Jan 21;12(1):e1005331</RefSource>                <PMID Version="1">26794909</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 1994 Sep 28;272(12):947-54</RefSource>                <PMID Version="1">8084062</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Histopathology. 2008 Mar;52(4):445-56</RefSource>                <PMID Version="1">18315597</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2015 Aug;24(4):384-90</RefSource>                <PMID Version="1">25987488</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Oncol Pract. 2010 Jul;6(4):195-7</RefSource>                <PMID Version="1">21037871</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mod Pathol. 2005 Jul;18(7):891-7</RefSource>                <PMID Version="1">15803183</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2014 May;145(1):177-83</RefSource>                <PMID Version="1">24658893</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Cancer Res. 2014 Jul 16;4(4):337-52</RefSource>                <PMID Version="1">25057437</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2008 May;109(1):123-39</RefSource>                <PMID Version="1">17578664</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2006 Feb 15;98(4):262-72</RefSource>                <PMID Version="1">16478745</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2013;15(5):R84</RefSource>                <PMID Version="1">24041225</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2014 Nov 29;14:895</RefSource>                <PMID Version="1">25433805</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2014 Aug 1;135(3):702-9</RefSource>                <PMID Version="1">24375396</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Causes Control. 1997 May;8(3):420-43</RefSource>                <PMID Version="1">9498903</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncology. 2012;83(5):257-63</RefSource>                <PMID Version="1">22964749</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74</RefSource>                <PMID Version="1">11553815</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2006 Jun 7;295(21):2492-502</RefSource>                <PMID Version="1">16757721</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2311-21</RefSource>                <PMID Version="1">25143359</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>23</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>23</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>23</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30241184</ArticleId>            <ArticleId IdType="doi">10.1200/JGO.2017.010082</ArticleId>            <ArticleId IdType="pmc">PMC6180747</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>